Page last updated: 2024-10-18

dalteparin and Atheroma

dalteparin has been researched along with Atheroma in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Dalteparin may inhibit atherosclerotic lesions by downregulating the expression of LOX-1 protein."1.42Effect of dalteparin on atherosclerotic lesion formation in apolipoprotein E-deficient mice. ( Bao, H; Chen, D; Li, W; Miao, Y; Su, L; Yan, Z; Zhang, Q, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artico, M1
Riganò, R1
Buttari, B1
Profumo, E1
Ionta, B1
Bosco, S1
Rasile, M1
Bianchi, E1
Bruno, M1
Fumagalli, L1
Su, L1
Zhang, Q1
Bao, H1
Li, W1
Miao, Y1
Yan, Z1
Chen, D1

Other Studies

2 other studies available for dalteparin and Atheroma

ArticleYear
Protective role of parnaparin in reducing systemic inflammation and atherosclerotic plaque formation in ApoE-/- mice.
    International journal of molecular medicine, 2011, Volume: 27, Issue:4

    Topics: Animals; Apolipoproteins E; Arteries; Disease Models, Animal; Fatty Liver; Fibrinolytic Agents; Gene

2011
Effect of dalteparin on atherosclerotic lesion formation in apolipoprotein E-deficient mice.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2015, Volume: 21, Issue:3

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Dalteparin; Down-Regulation; Mice; Mice, Knockout; Plaq

2015
chemdatabank.com